Award
Delivery Order #SPE2DR26FCKYF
DMS Pharmaceutical Group Supplies Midazolam for Federal Healthcare Needs
Buyer
Defense Logistics Agency
Award Amount
$27.90
Ceiling
$27.90
Awarded
June 24, 2026
Period of Performance
Jun 24, 2026 – Jun 25, 2026
Identifier
SPE2DR26FCKYF
NAICS
325411
This is a delivery order under DMS Pharmaceutical Group Inc.’s parent indefinite-delivery contract, a flexible vehicle for ordering pharmaceutical products for European operations. The order covers midazolam hydrochloride injection, specified as 5 mg/mL vials, for delivery to Park Ridge, Illinois. DMS Pharmaceutical Group Inc. supplies pharmaceutical products and services; no parent company beyond the named recipient is identified in the available data. The medication supports healthcare operations by providing an injectable medicine used in clinical care. The order is associated with the parent contract’s long-term period of performance, while this individual order has a very short performance window. The available record does not identify whether the order was competed or sole-source, provide a solicitation or acquisition program, or list subcontractors or earlier related orders. No transaction history is provided. Specific dates and dollar amounts are omitted as requested.
Description
4572443234!MIDAZOLAM HCL 5 MG/ML VIALML